A groundbreaking study from Baylor College of Medicine has shed new light on the molecular dynamics of CAR T cells, a revolutionary cancer therapy that harnesses the power of the immune system to target and destroy cancer cells.
The Sprint vs. Marathon Approach: Understanding CAR T Cell Behavior
Researchers found that two common types of CAR T cells employ distinct strategies to kill cancer cells. The first type, CD28.ζ-CAR T cells, are like sprinters – they quickly and efficiently eliminate cancer cells, but their activity is short-lived. In contrast, 4-1BB.ζ-CAR T cells are like marathon runners – they consistently kill cancer cells over a prolonged period.
Uncovering the Molecular Dynamics of CAR T Cell Behavior
To understand the molecular mechanisms behind this behavior, researchers examined the immune synapse, the critical site where CAR T cells bind to cancer cells. They found that CD28.ζ-CAR molecules rapidly shuttle through the immune synapse, enabling fast CAR T cell recovery and “serial killing” of cancer cells. In contrast, 4-1BB.ζ-CAR molecules linger in the lipid rafts and immune synapse, leading to sustained “collaborative” killing of tumor cells.
Adapting CAR T Cells for Hard-to-Treat Tumors
These findings have significant implications for the development of CAR T cell therapies, particularly for hard-to-treat tumors. By understanding the molecular dynamics of CAR T cell behavior, researchers can design more effective therapies that adapt to the biology of the disease.
“Tumors are very sophisticated. We need to adapt our tools to the biology of the disease. This may involve using multiple tools that work in different ways at different stages,” said Dr. Nabil Ahmed, senior author of the study.
The Future of CAR T Cell Therapy
This study represents a major breakthrough in our understanding of CAR T cell behavior and has significant implications for the development of more effective cancer therapies. As researchers continue to unravel the molecular dynamics of CAR T cell behavior, we can expect to see the development of more sophisticated and effective therapies that harness the power of the immune system to target and destroy cancer cells.
Reference:
“Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells” 10 January 2025, Science Advances. DOI: 10.1126/sciadv.adq8114
